Jailendra Singh
Stock Analyst at Truist Securities
(0.91)
# 3,836
Out of 4,981 analysts
184
Total ratings
27.08%
Success rate
-21.32%
Average return
Main Sectors:
Stocks Rated by Jailendra Singh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PHR Phreesia | Maintains: Buy | $35 → $36 | $24.19 | +48.82% | 7 | Sep 8, 2025 | |
| HIMS Hims & Hers Health | Maintains: Hold | $48 → $37 | $55.50 | -33.33% | 11 | Aug 18, 2025 | |
| ICLR ICON Public Limited Company | Maintains: Buy | $187 → $234 | $175.01 | +33.71% | 10 | Jul 25, 2025 | |
| MEDP Medpace Holdings | Maintains: Hold | $298 → $436 | $490.64 | -11.14% | 5 | Jul 23, 2025 | |
| IQV IQVIA Holdings | Maintains: Buy | $209 → $235 | $187.22 | +25.52% | 16 | Jul 23, 2025 | |
| WAY Waystar Holding | Maintains: Buy | $50 → $51 | $37.36 | +36.51% | 3 | Jul 17, 2025 | |
| PGNY Progyny | Maintains: Hold | $24 → $27 | $22.51 | +19.95% | 10 | Jul 17, 2025 | |
| EVH Evolent Health | Maintains: Buy | $14 → $16 | $9.02 | +77.38% | 6 | Jul 17, 2025 | |
| DOCS Doximity | Maintains: Hold | $52 → $61 | $71.03 | -14.12% | 9 | Jul 17, 2025 | |
| HNGE Hinge Health | Initiates: Buy | $48 | $57.63 | -16.71% | 1 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $10 → $9 | $7.68 | +17.19% | 16 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 → $28 | $22.79 | +22.86% | 7 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6.5 → $5.5 | $4.19 | +31.26% | 12 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $12 → $7.5 | $6.64 | +12.95% | 7 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $46 | $29.83 | +54.21% | 5 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $261 → $210 | $276.43 | -24.03% | 7 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $14 | $10.97 | +27.62% | 1 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6.4 → $6.5 | $1.07 | +507.48% | 8 | May 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $13 | $4.00 | +225.00% | 11 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $42 → $43 | $5.34 | +705.24% | 6 | Feb 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $30 → $24 | $4.15 | +479.01% | 2 | Feb 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $14 → $4 | $2.09 | +91.39% | 4 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $58 | $152.24 | -61.90% | 2 | Feb 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $90 → $45 | $4.95 | +809.09% | 7 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $230 → $333 | $711.42 | -53.19% | 6 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $9 | $3.06 | +194.12% | 2 | May 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $26.63 | - | 3 | Jan 15, 2021 |
Phreesia
Sep 8, 2025
Maintains: Buy
Price Target: $35 → $36
Current: $24.19
Upside: +48.82%
Hims & Hers Health
Aug 18, 2025
Maintains: Hold
Price Target: $48 → $37
Current: $55.50
Upside: -33.33%
ICON Public Limited Company
Jul 25, 2025
Maintains: Buy
Price Target: $187 → $234
Current: $175.01
Upside: +33.71%
Medpace Holdings
Jul 23, 2025
Maintains: Hold
Price Target: $298 → $436
Current: $490.64
Upside: -11.14%
IQVIA Holdings
Jul 23, 2025
Maintains: Buy
Price Target: $209 → $235
Current: $187.22
Upside: +25.52%
Waystar Holding
Jul 17, 2025
Maintains: Buy
Price Target: $50 → $51
Current: $37.36
Upside: +36.51%
Progyny
Jul 17, 2025
Maintains: Hold
Price Target: $24 → $27
Current: $22.51
Upside: +19.95%
Evolent Health
Jul 17, 2025
Maintains: Buy
Price Target: $14 → $16
Current: $9.02
Upside: +77.38%
Doximity
Jul 17, 2025
Maintains: Hold
Price Target: $52 → $61
Current: $71.03
Upside: -14.12%
Hinge Health
Jun 16, 2025
Initiates: Buy
Price Target: $48
Current: $57.63
Upside: -16.71%
May 27, 2025
Maintains: Hold
Price Target: $10 → $9
Current: $7.68
Upside: +17.19%
Apr 10, 2025
Maintains: Buy
Price Target: $27 → $28
Current: $22.79
Upside: +22.86%
Apr 10, 2025
Maintains: Hold
Price Target: $6.5 → $5.5
Current: $4.19
Upside: +31.26%
Apr 10, 2025
Maintains: Hold
Price Target: $12 → $7.5
Current: $6.64
Upside: +12.95%
Mar 18, 2025
Maintains: Buy
Price Target: $50 → $46
Current: $29.83
Upside: +54.21%
Jan 13, 2025
Maintains: Hold
Price Target: $261 → $210
Current: $276.43
Upside: -24.03%
Jul 2, 2024
Maintains: Buy
Price Target: $17 → $14
Current: $10.97
Upside: +27.62%
May 24, 2024
Maintains: Hold
Price Target: $6.4 → $6.5
Current: $1.07
Upside: +507.48%
May 4, 2022
Maintains: Neutral
Price Target: $16 → $13
Current: $4.00
Upside: +225.00%
Feb 28, 2022
Maintains: Neutral
Price Target: $42 → $43
Current: $5.34
Upside: +705.24%
Feb 24, 2022
Maintains: Neutral
Price Target: $30 → $24
Current: $4.15
Upside: +479.01%
Feb 8, 2022
Downgrades: Neutral
Price Target: $14 → $4
Current: $2.09
Upside: +91.39%
Feb 4, 2022
Maintains: Neutral
Price Target: $60 → $58
Current: $152.24
Upside: -61.90%
Jan 7, 2022
Downgrades: Underperform
Price Target: $90 → $45
Current: $4.95
Upside: +809.09%
Jan 7, 2022
Upgrades: Outperform
Price Target: $230 → $333
Current: $711.42
Upside: -53.19%
May 19, 2021
Maintains: Neutral
Price Target: $10 → $9
Current: $3.06
Upside: +194.12%
Jan 15, 2021
Downgrades: Underperform
Price Target: n/a
Current: $26.63
Upside: -